Ads
related to: generic brand for lantus
Search results
Results from the WOW.Com Content Network
Insulin glargine sold under the brand name Lantus among others is a long-acting modified form of medical insulin, used in the management of type 1 and type 2 diabetes. [7] It is injected just under the skin . [ 7 ]
Brand Name(s) Generic Name Sales Q1 2014 Sales ($000) Change from Q4 2013 ... Lantus Solostar: Insulin glargine: 939,691: 9.39%: Sanofi-Aventis: Diabetes mellitus ...
Insulin glargine/lixisenatide, sold under the brand name Soliqua among others, is a fixed-dose combination medication that combines insulin glargine and lixisenatide and is used to treat diabetes. The most common side effects include hypoglycemia (low blood glucose), diarrhea, vomiting and nausea (feeling sick).
The site in Frankfurt’s Hoechst district is known for producing the company’s insulin brand, Lantus. Also Read: Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case ...
Lixisenatide is used as adjunct to diet and exercise to treat type 2 diabetes. [3] In the European Union, its use is limited to complementing insulin therapy. [2] [4] As of 2017 it is unclear if they affect a person's risk of death.
Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales. Abbreviations are used in the list as follows: INN = International Nonproprietary Name; BAN = British Approved Name; USAN = United States Adopted Name; Two-letter codes for countries
Ads
related to: generic brand for lantus